Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/intqhc/mzae025 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diagnostic and Therapeutic Strategies for Intraoperative and Postoperative Hypocalcemia in Pediatric Thyroidectomy Patients: A Single-Center Experience.
J Pediatr Surg
September 2025
Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland; Department of Pediatric and Adolescent Endocrinology, University Children's Hospital of Krakow, Krakow, Poland.
Background: The primary goals of surgical management in thyroid disorders are the treatment of malignancy, goiter, and thyrotoxicosis, while adhering to the principle of 'primum non nocere'. Hypocalcemia is among the most common complications, primarily resulting from inadvertent injury to the parathyroid glands.
Methods: A retrospective analysis of 2015-2023 records of Polish pediatric patients who underwent thyroid surgery.
Biocompatibility in hemodialysis: artificial membrane and human blood interactions.
BMC Nephrol
August 2025
Department of Pharmacy, School of Pharmacy, Faculty of Chemistry and Pharmacy, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Macul, Santiago, Chile.
Hemodialysis, a cornerstone therapy for chronic kidney disease, represented a crucial advance in the evolution of artificial organs. While its success is largely due to its efficiency in removing uremic toxins, an equally important challenge is to uphold the primum non nocere principle by minimizing the harmful effects of membrane-blood interactions. This review examines the complex mechanisms and key interactions underlying membrane biocompatibility, including complement activation, inflammation, and coagulation disturbances, paving the way for their clinical implications.
View Article and Find Full Text PDFLessons from coronary physiology: primum non nocere.
Eur Heart J
August 2025
Oxford Heart Centre, John Radcliffe Hospital, Oxford University Hospitals, Oxford OX3 9DU, UK.
Romosozumab for Glucocorticosteroid-Induced Osteoporosis in Patients With Autoimmune Blistering Diseases: Primum Non Nocere.
Int J Dermatol
August 2025
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Primum non nocere: why to use ultrasound to predict when instrumental vaginal delivery is feasible.
Am J Obstet Gynecol
July 2025
Obstetrics and Gynecology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.